---
title: "TERN.US (TERN.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/TERN.US/news.md"
symbol: "TERN.US"
name: "TERN.US"
parent: "https://longbridge.com/en/quote/TERN.US.md"
datetime: "2026-05-20T19:24:18.773Z"
locales:
  - [en](https://longbridge.com/en/quote/TERN.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/TERN.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/TERN.US/news.md)
---

# TERN.US (TERN.US) — Related News

### [](https://longbridge.com/en/news/286786315.md)
*2026-05-18T14:20:40.000Z*
> Merck & Co. is seeking to raise approximately $6 billion through the issuance of seven bonds with varying maturities to 

### [MSD concludes Terns acquisition to expand CML pipeline](https://longbridge.com/en/news/285349368.md)
*2026-05-06T08:47:44.000Z*
> A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings.

### [Sector Update: Health Care Stocks Advance Tuesday Afternoon](https://longbridge.com/en/news/285248248.md)
*2026-05-05T17:56:00.000Z*
> Health care stocks saw a rise on Tuesday, with the NYSE Health Care Index and the State Street Health Care Select Sector

### [Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Receives Average Recommendation of "Hold" from Analysts](https://longbridge.com/en/news/285163264.md)
*2026-05-05T06:40:05.000Z*
> Terns Pharmaceuticals, Inc. (NASDAQ:TERN) has received a consensus recommendation of "Hold" from fifteen analysts. The b

### [Merck Completes Acquisition of Terns Pharmaceuticals, Inc. | MRK Stock News](https://longbridge.com/en/news/285209655.md)
*2026-05-05T04:45:33.000Z*
> Merck Completes Acquisition of Terns Pharmaceuticals, Inc. | MRK Stock News

### [Terns Pharmaceuticals (NASDAQ:TERN) Earns Market Perform Rating from Oppenheimer](https://longbridge.com/en/news/284236051.md)
*2026-04-27T14:33:40.000Z*
> Oppenheimer has reiterated a "market perform" rating for Terns Pharmaceuticals (NASDAQ:TERN) with a target price of $58.

### [Terns Pharmaceuticals Announces FDA Breakthrough Therapy Designation Granted to TERN-701 for Certain Patients with Chronic Myeloid Leukemia | TERN Stock News](https://longbridge.com/en/news/284211271.md)
*2026-04-27T04:05:37.000Z*
> Terns Pharmaceuticals Announces FDA Breakthrough Therapy Designation Granted to TERN-701 for Certain Patients with Chron